16.01.2014 • Topics

Helsinn Reaps Benefits of Cytotoxic Molecule Demand

Continue with login

No account yet?

Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.

Company

Helsinn Chemicals SA

Via Industria 24
6710 Biasca
Switzerland

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Predictive Simulation in Pharma Production

most read

Topics • Chemistry

Relocation of Chemicals Production Footprint in Full Swing

A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.

Topics • Innovation

Lead or Lag: Europe’s AI Materials Race

How AI and Robotics are reshaping the race for materials discovery.

20 Years of CHEManager International

Incredible but true: CHEManager International is celebrating its 20th anniversary!

Topics • Pharma

Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma

Part 3: Seven Theses for successful Digitalization in Pharma

Topics • Pharma

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma

Part 1: Building a Business Case for Pharma 4.0